Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Huang Jane Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Huang Jane (President, CMO) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Exercised 9,375 restricted stock units @ $0
07/06/2023 4 Huang Jane (President, CMO) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Paid exercise price by delivering 3,242 shares @ $4.65, valued at $15.1k
Exercised 9,375 restricted stock units @ $0
06/08/2023 4 Huang Jane (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
02/09/2023 4 Huang Jane (President, CMO) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 150,000 options to buy @ $7.2, valued at $1.1M
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/06/2022 3 Huang Jane (President, CMO) has filed a Form 3 on Prelude Therapeutics Inc
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2021 4 Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.
Txns: Exercised 1,500 shares @ $119.96, valued at $179.9k
Sold 200 shares @ $376.155, valued at $75.2k
Sold 300 shares @ $377.14, valued at $113.1k
Sold 100 shares @ $377.92, valued at $37.8k
Sold 100 shares @ $379.8839, valued at $38k
Sold 200 shares @ $381.41, valued at $76.3k
Sold 100 shares @ $382.42, valued at $38.2k
Sold 100 shares @ $384.16, valued at $38.4k
Sold 100 shares @ $385.28, valued at $38.5k
Sold 300 shares @ $387.94, valued at $116.4k
Exercised 19,500 options to buy @ $0
10/21/2021 4 Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.
Txns: Exercised 1,500 shares @ $119.96, valued at $179.9k
Sold 200 shares @ $362.045, valued at $72.4k
Sold 100 shares @ $370.14, valued at $37k
Sold 100 shares @ $371.65, valued at $37.2k
Sold 400 shares @ $373.75, valued at $149.5k
Sold 400 shares @ $375.08, valued at $150k
Sold 200 shares @ $376.36, valued at $75.3k
Sold 100 shares @ $377.71, valued at $37.8k
Exercised 19,500 options to buy @ $0
09/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2021 4 Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.
Txns: Exercised 6,914 shares @ $160.4, valued at $1.1M
Exercised 8,831 shares @ $119.96, valued at $1.1M
Exercised 5,255 shares @ $174.43, valued at $916.6k
Sold 2,379 shares @ $330.5264, valued at $786.3k
Sold 6,523 shares @ $331.7875, valued at $2.2M
Sold 8,177 shares @ $332.7121, valued at $2.7M
Sold 2,823 shares @ $333.6385, valued at $941.9k
Sold 1,000 shares @ $334.846, valued at $334.8k
Sold 98 shares @ $335.76, valued at $32.9k
Exercised 89,882 options to buy @ $0
Exercised 114,803 options to buy @ $0
06/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2020 4 Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.
Txns: Exercised 1,500 shares @ $29.49, valued at $44.2k
Sold 200 shares @ $244.8952, valued at $49k
Sold 300 shares @ $246.0233, valued at $73.8k
Sold 200 shares @ $247.975, valued at $49.6k
Sold 200 shares @ $249.875, valued at $50k
Sold 300 shares @ $251.5833, valued at $75.5k
Sold 300 shares @ $252.8633, valued at $75.9k
Exercised 19,500 options to buy @ $0
12/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2020 4 Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.
Txns: Exercised 1,500 shares @ $29.49, valued at $44.2k
Sold 1,261 shares @ $299.8765, valued at $378.1k
Sold 139 shares @ $300.7032, valued at $41.8k
Sold 100 shares @ $301.51, valued at $30.2k
Exercised 19,500 options to buy @ $0
10/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/08/2020 4 Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.
Txns: Sold 1,000 shares @ $232.2469, valued at $232.2k
Sold 1,411 shares @ $232.9354, valued at $328.7k
Sold 500 shares @ $234.17, valued at $117.1k
Sold 217 shares @ $235.2133, valued at $51k
09/01/2020 4 Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.
Txns: Exercised 3,000 shares @ $29.49, valued at $88.5k
Sold 800 shares @ $240.1516, valued at $192.1k
Sold 200 shares @ $240.86, valued at $48.2k
Sold 1,000 shares @ $242.413, valued at $242.4k
Sold 700 shares @ $243.4886, valued at $170.4k
Sold 300 shares @ $244.9267, valued at $73.5k
Exercised 39,000 options to buy @ $0
07/31/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/09/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy